These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9603633)

  • 41. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia.
    Kader AA; Kumar AK
    Saudi Med J; 2004 May; 25(5):570-4. PubMed ID: 15138522
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Drug resistance of imipenem-resistant Gram-negative bacilli in coal worker's pneumoconiosis chronic obstructive pulmonary disease patients with lower respiratory tract infection].
    Liu PY; Sun YX; Gu DQ; Cheng JL
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 Sep; 31(9):700-2. PubMed ID: 24064132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in South African hospitals (SMART Study 2004-2009): impact of the new carbapenem breakpoints.
    Brink AJ; Botha RF; Poswa X; Senekal M; Badal RE; Grolman DC; Richards GA; Feldman C; Boffard KD; Veller M; Joubert I; Pretorius J
    Surg Infect (Larchmt); 2012 Feb; 13(1):43-9. PubMed ID: 22220506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of vim- and ipm-type metallo-beta-lactamases in Pseudomonas aeruginosa clinical isolates.
    Sepehriseresht S; Boroumand MA; Pourgholi L; Sotoudeh Anvari M; Habibi E; Sattarzadeh Tabrizi M
    Arch Iran Med; 2012 Nov; 15(11):670-3. PubMed ID: 23102242
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.
    Piéboji JG; Koulla-Shiro S; Ngassam P; Adiogo D; Njine T; Ndumbe P
    Int J Infect Dis; 2004 May; 8(3):147-54. PubMed ID: 15109589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Analysis of drug resistance of Pseudomonas aeruginosa and use of antibiotics in burn wards during 6 years].
    Dou Y; Zhang Q
    Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):9-14. PubMed ID: 24684983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections at a medical center in Taiwan: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2002-2006.
    Chen WY; Jang TN; Huang CH; Hsueh PR
    J Microbiol Immunol Infect; 2009 Aug; 42(4):317-23. PubMed ID: 19949755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalent nosocomial gram negative aerobic bacilli and their antimicrobial susceptibility pattern in intensive care unit.
    Zafar A
    J Pak Med Assoc; 1999 Jul; 49(7):169-72. PubMed ID: 10599205
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro activity of aztreonam against gram negative bacteria from clinical specimens and its comparison with other commonly used antibiotics.
    Qadri SM; Belobraydic KA
    Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):223-6. PubMed ID: 3088346
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Imipenem-cilastatin sodium, a broad-spectrum carbapenem antibiotic combination.
    Pastel DA
    Clin Pharm; 1986 Sep; 5(9):719-36. PubMed ID: 3530614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Species distribution and antimicrobial susceptibility of gram-negative aerobic bacteria in hospitalized cancer patients.
    Ashour HM; El-Sharif A
    J Transl Med; 2009 Feb; 7():14. PubMed ID: 19228413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibiotic resistance among Gram-negative non-fermentative bacteria at a teaching hospital in Saudi Arabia.
    Eltahawy AT; Khalaf RM
    J Chemother; 2001 Jun; 13(3):260-4. PubMed ID: 11450883
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metallo-beta-lactamase-producing Gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: continued prevalence of VIM-producing Pseudomonas spp. and increase of IMP-producing Acinetobacter spp.
    Lee K; Ha GY; Shin BM; Kim JJ; Kang JO; Jang SJ; Yong D; Chong Y;
    Diagn Microbiol Infect Dis; 2004 Sep; 50(1):51-8. PubMed ID: 15380278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antimicrobial susceptibility of bacterial isolates from burn units in Gaza.
    Elmanama AA; Laham NA; Tayh GA
    Burns; 2013 Dec; 39(8):1612-8. PubMed ID: 23664775
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro activity of imipenem and six other beta-lactam antibiotics against aminoglycoside resistant gram-negative bacilli.
    Bujdáková H; Kallová J; Lausová A; Kettner M
    Microbios; 1995; 84(339):87-90. PubMed ID: 8628124
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Meropenem: microbiologic perspective].
    García-Rodríguez JA; García Sánchez E; Fresnadillo Martínez MJ
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():2-7. PubMed ID: 9410064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Bactericidal activity and capacity for selection of mutants resistant to imipenmen and meropenem in strains of Proteus, Morganella and Providencia].
    Villar HE; Longo L; Arena MF; Laurino G; Hoffman M
    Enferm Infecc Microbiol Clin; 1998; 16(6):261-4. PubMed ID: 9763741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The in vitro activity of FCE 22101 against gram-negative aerobic isolates resistant to third generation cephalosporins.
    Voutsinas D; Galanakis N; Giamarellou H
    J Chemother; 1994 Apr; 6(2):99-101. PubMed ID: 8077992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changing trends in bacteriology of burns in the burns unit, Delhi, India.
    Singh NP; Goyal R; Manchanda V; Das S; Kaur I; Talwar V
    Burns; 2003 Mar; 29(2):129-32. PubMed ID: 12615458
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The in-vitro activity of biapanem against 964 clinical isolates of aerobic bacteria.
    Raymond NJ; Bremner DA
    J Antimicrob Chemother; 1995 May; 35(5):681-6. PubMed ID: 7592182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.